Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Current Gene Therapy|December 27, 2013
Targeted delivery of growth factors by HSV-mediated gene transfer for peripheral neuropathyMunmun ChattopadhyayCurrent Drug Targets|March 20, 2018
Early Urinary Markers for Diabetic and Other Kidney DiseasesVikram Thakur, Munmun ChattopadhyayCytokine|May 14, 2013
RETRACTED: Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetesChristina Galloway, Munmun ChattopadhyayBrain, Behavior, and Immunity|June 1, 2014
Decrease in neuroimmune activation by HSV-mediated gene transfer of TNFα soluble receptor alleviates pain in rats with diabetic neuropathyKathryn L Maier Ortmann, Munmun ChattopadhyayInternational Journal of Molecular Sciences|February 6, 2020
High-Mobility Group Box 1 Protein Signaling in Painful Diabetic NeuropathyVikram Thakur, Jayanarayanan Sadanandan, Munmun ChattopadhyayNutrients|June 27, 2020
Role of Minerals and Trace Elements in Diabetes and Insulin ResistancePallavi Dubey, Vikram Thakur, Munmun ChattopadhyayThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 27, 2008
Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathyMunmun Chattopadhyay, Marina Mata, David J FinkExpert Opinion on Biological Therapy|April 14, 2006
Gene therapy for the treatment of sensory neuropathyMarina Mata, Munmun Chattopadhyay, David J FinkCurrent Diabetes Reports|November 8, 2008
Gene therapy for the treatment of diabetic neuropathyMarina Mata, Munmun Chattopadhyay, David J FinkEuropean Journal of Pain (London, England)|April 14, 2011
Vector-mediated release of GABA attenuates pain-related behaviors and reduces Na(V)1.7 in DRG neuronsMunmun Chattopadhyay, Marina Mata, David J FinkPageof 4